The frequent exacerbator phenotype in asthma: a clinical characterization

A. Sprio (Orbassano, Italy), V. Carriero (Orbassano, Italy), S. Levra (Orbassano, Italy), C. Botto (Orbassano, Italy), F. Bertolini (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)

Source: Virtual Congress 2020 – Phenotypes of obstructive diseases
Session: Phenotypes of obstructive diseases
Session type: E-poster session
Number: 1252
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Sprio (Orbassano, Italy), V. Carriero (Orbassano, Italy), S. Levra (Orbassano, Italy), C. Botto (Orbassano, Italy), F. Bertolini (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy). The frequent exacerbator phenotype in asthma: a clinical characterization. 1252

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The frequent exacerbator phenotype in bronchiectasis: predictors and particularities
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018



Exacerbation phenotypes of frequent versus non-frequent exacerbators among severe asthma patients
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


Defining the clinical clusters of severe asthma within UBIOPRED
Source: International Congress 2015 – Fingerprinting severe asthma
Year: 2015



Can we consider the "frequent exacerbator" a reliable COPD phenotype?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015

Improved definition of severe asthma phenotypes
Source: International Congress 2014 – PG05 Severe asthma – highlights from the ERS/ATS workshop
Year: 2014




Frequent COPD exacerbators are not a stabile phenotype
Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases
Year: 2019


The frequent exacerbator in real-life: an analysis of the DACCORD study
Source: International Congress 2019 – COPD treatment: cohorts and real-world studies
Year: 2019

Neutrophil-to-lymphocyte ratio predicts clinical outcome of severe acute exacerbation of COPD in frequent exacerbators
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021

Inflammatory phenotypes of severe exacerbation of COPD, a clinico-laboratory characterization.
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021

Clinical phenotypes of severe asthma: children
Source: Eur Respir Monogr 2019; 84: 64-81
Year: 2019


Clinical phenotypes of severe asthma: adults
Source: Eur Respir Monogr 2019; 84: 48-63
Year: 2019


Bronchial Thermosplaty and severe asthma with frequent severe exacerbations : a controlled study.
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Comparison of small airways disease measures between frequent and infrequent COPD exacerbators
Source: International Congress 2019 – Respiratory function assessment in disease
Year: 2019

Dynapenia in COPD exacerbation: what is its relevance in clinical prognosis?
Source: International Congress 2017 – Assessing functional outcomes in respiratory physiotherapy
Year: 2017

Loss of smell: a clinical marker of severe asthma
Source: International Congress 2018 – Clinical markers of asthma
Year: 2018


Immunoglobulin G and subclasses in COPD exacerbator phenotype: levels in exacerbation time and clinical stability
Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough
Year: 2021


Management of difficult-to-treat severe asthma
Source: Eur Respir Mon 2011; 51: 282-296
Year: 2011


Spirometry quality in patients with COPD exacerbation, related to the “frequent exacerbator” phenotype
Source: Annual Congress 2013 –Reference, reliability and risk: advances in lung function
Year: 2013

Ykl-40 and phenotyping of severe asthma
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019


COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014